Ginkgo Bioworks Holdings, Inc. (BMV:DNA)

Market Cap	7.14B -46.8%
Revenue (ttm)	3.06B -25.1%
Net Income	-5.63B
EPS	-101.53
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	54
Average Volume	317
Open	176.13
Previous Close	176.13
Day's Range	176.13 - 176.13
52-Week Range	170.00 - 289.00
Beta	n/a
RSI	29.87
Earnings Date	Feb 25, 2026

About Ginkgo Bioworks Holdings

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell programming in the United States. It operates through Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics and antibody developability Datapoints services, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms...

• Industry: Commercial Physical and Biological Research
• Founded: 2008
• Employees: 834
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: DNA

Financial Performance

In 2025, Ginkgo Bioworks Holdings's revenue was $170.16 million, a decrease of -25.06% compared to the previous year's $227.04 million. Losses were -$312.76 million, -42.83% less than in 2024.

Financial numbers in USD